Median levels of MMP-10, MMP-3, and CA 15-3 in patients with stages III and IV BC were significantly elevated as compared with patients with stage I of the disease (p = 0.019, p = 0.018, and p = 0.003, respectively). This evidence concerns the gene MMP3 and breast cancer.